Among the affected lipids, the diminished odd-chain triglycerides are of particular interest as they were also diminished in DCM independent of LMNA mutation and thus could be considered as DCM risk marker candidates but this warrants further studies. The gene discussed is LMNA; the disease is familial dilated cardiomyopathy.